Stock 603456 ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Zhejiang Jiuzhou Pharmaceutical Co., Ltd

Equities

603456

CNE100001W36

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-23 pm EDT 		5-day change 1st Jan Change
15.22 CNY -1.55% Intraday chart for Zhejiang Jiuzhou Pharmaceutical Co., Ltd -4.40% -37.13%
May. 23 Jiuzhou Pharmaceutical Plans CRO in Germany MT
Apr. 24 Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Jiuzhou Pharmaceutical Plans CRO in Germany
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Jiuzhou Pharmaceutical Gets Nod to Market Sitagliptin Metformin Tablets; Shares Drop 4%
Jiuzhou Pharma to Build $42 Million CRO Platform in Japan
Zhejiang Jiuzhou Pharmaceutical Co., Ltd announces an Equity Buyback for CNY 100 million worth of its shares.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd authorizes a Buyback Plan.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Jiuzhou Pharmaceutical Logs Double-Digit Growth in H1 Earnings on Expanded CDMO Operations
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Jiuzhou Pharma to Set Up Singapore Subsidiary
Jiuzhou Pharma Gets Drug Registration Certificate for Carbamazepine Sustained-release Tablets
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
Zhejiang Jiuzhou Pharmaceutical Co., Ltd completed the acquisition of Ruihua Pharmaceutical Co., Ltd. from Sandoz Pharmaceutical Co., Ltd.
Jiuzhou Pharma Nets 2.5 Billion Yuan from Share Placement
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
Jiuzhou Pharma to Purchase Factory From Sandoz China for $26 Million
Zhejiang Jiuzhou Pharmaceutical Co., Ltd announces an Equity Buyback for CNY 100 million worth of its shares.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd authorizes a Buyback Plan.
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 603456 Stock
  4. News Zhejiang Jiuzhou Pharmaceutical Co., Ltd
  5. Other languages